Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Turning the Tide on Cancer

Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need


7th Annual LD Micro Invitational Conference
 June 7, 2017
 11:30am - 12:00pm PDT

Trovagene CEO, Bill Welch, will be presenting at the 7th Annual LD Micro Invitational Conference June 7, 2017 at 11:30 AM PDT at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.  The presentation will be webcast live at http://wsw.com/website/ldmicro12/trov and can also be accessed through the Trovagene website at www.trovagene.investorroom.com.  A replay of the presentation will be available and archived for 90 days.